A comprehensive study of phenylalanine hydroxylase gene mutations in the Iranian phenylketonuria patients.

Iranian population Mutation analysis Phenyalanine hydroxylase Phenylketonuria

Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 23 07 2018
revised: 09 10 2018
accepted: 24 10 2018
pubmed: 6 11 2018
medline: 21 1 2020
entrez: 4 11 2018
Statut: ppublish

Résumé

Phenylketonuria (PKU) is a metabolic disorder caused by mutations in the phenylalanine hydroxylase (PAH) gene. After thalassemia, PKU is considered as the most common autosomal recessive diseases in the Iranian population. Therefore, an efficient diagnostic strategy is required to identify disease-causing mutations in this population. Following our first report in 2003, here we presented a comprehensive study on the mutation spectrum of the PAH gene in the Iranian population. This study was performed on 280 unrelated chromosomes from 140 Iranian patients with classic PKU. All 13 exons as well as exon-intron boundaries of the PAH gene were analyzed by direct DNA sequencing. Thirty four different mutations were identified by a mutation detection rate of 100%. IVS10-11G > A, p.P281L, R261Q, p.F39del and IVS11+1G > C were the most prevalent mutations with frequencies of 26.07%, 19.3%, 12.86%, 6.07 and 3.93%, respectively. All other mutations represented a relative frequency less than 3.5%. The data from this study provided a comprehensive spectrum of the PAH gene mutations which can facilitate carrier detection and prenatal diagnosis of PKU disease in the Iranian population.

Identifiants

pubmed: 30389586
pii: S1769-7212(18)30562-7
doi: 10.1016/j.ejmg.2018.10.011
pii:
doi:

Substances chimiques

Phenylalanine Hydroxylase EC 1.14.16.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103559

Informations de copyright

Published by Elsevier Masson SAS.

Auteurs

Maryam Shaykholeslam Esfahani (MS)

Division of Genetics, Department of Biology, Faculty of Science, University of Isfahan, Isfahan, IR, Iran.

Sadeq Vallian (S)

Division of Genetics, Department of Biology, Faculty of Science, University of Isfahan, Isfahan, IR, Iran. Electronic address: svallian@sci.ui.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH